Acute Effects of Cricket Fast Bowling on Bone Turnover and Signaling Markers
1 other identifier
interventional
14
1 country
1
Brief Summary
The goal of this study is to investigate the acute effects of cricket fast bowling on the bone turnover and signaling markers in healthy young males. The main question aims to answer: • Does a single bout acute fast bowling change serum C-terminal telopeptide of type I collagen (CTX-I) and other bone turnover and signaling markers levels? Participants complete both the bowling and control trials, with a minimum washout period of one week between trials. During each trial, blood samples are collected at three time points: pre-, immediately post, and 2-hour post bowling/rest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2023
CompletedFirst Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
December 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 3, 2025
November 1, 2025
2.9 years
November 14, 2025
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum C-terminal telopeptide of type I collagen (CTX-I) concentration
Serum CTX-I concentration is measured using electrochemiluminescence immunoassay (ECLIA) and reported in nanograms per milliliter (ng/mL).
Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.
Secondary Outcomes (7)
Serum N-terminal propeptide of type I collagen (PINP) concentration
Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.
Serum parathyroid hormone (PTH) concentration
Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.
Serum sclerostin concentration
Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.
Serum dickkopf Wnt signaling pathway inhibitor 1 (DKK1) concentration
Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.
Serum osteoprotegerin (OPG) concentration
Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.
- +2 more secondary outcomes
Study Arms (2)
Arm Bowling + Control
EXPERIMENTALParticipants first perform the bowling trial, followed by the control trial, with a minimum interval of one week between the two trials.
Arm Control + Bowling
EXPERIMENTALParticipants first perform the control trial, followed by the bowling trial, with a minimum interval of one week between the two trials.
Interventions
During the bowling trial, participants perform 8 sets of 6 deliveries (bowl at match intensity throughout), followed by 2-hour rest. Each set is interspersed by a 3-minute randomized fielding simulation. During the control trial, participants rest throughout instead of bowling.
Eligibility Criteria
You may qualify if:
- Healthy male
- Aged 18 - 30
- Cricket fast bowlers (a ball speed of \~100kmh) playing for a university team or above, such as British Universities and Colleges Sport (BUCS) or University Centre of Cricketing Excellence (UCCE)
- Injury free for the last 3 months
You may not qualify if:
- Diagnosed with any disease or use of any medication that affects bone turnover
- Fracture experienced within the previous year/season
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loughborough Univeristy
Loughborough, Leicestershire, LE11 3TU, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine Brooke-Wavell
Loughborough University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 14, 2025
First Posted
December 3, 2025
Study Start
February 20, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
December 3, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share